Home
>
National Drug Code (NDC)
>
Retavase
Retavase - 24477-041-02 - (reteplase)
Drug Information of Retavase
| Product NDC: | 24477-041 |
| Proprietary Name: | Retavase |
| Non Proprietary Name: | reteplase |
| Active Ingredient(s): | & nbsp; reteplase |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Retavase
| Product NDC: | 24477-041 |
| Labeler Name: | EKR Therapeutics, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103786 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19961030 |
Package Information of Retavase
| Package NDC: | 24477-041-02 |
| Package Description: | 1 KIT in 1 BOX (24477-041-02) * 10 mL in 1 VIAL * 10 mL in 1 VIAL |
NDC Information of Retavase
| NDC Code | 24477-041-02 |
| Proprietary Name | Retavase |
| Package Description | 1 KIT in 1 BOX (24477-041-02) * 10 mL in 1 VIAL * 10 mL in 1 VIAL |
| Product NDC | 24477-041 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | reteplase |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 19961030 |
| Marketing Category Name | BLA |
| Labeler Name | EKR Therapeutics, Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
